Clinical Research Directory
Browse clinical research sites, groups, and studies.
Curcumin in Kidney Transplant Recipients
Sponsor: University of Illinois at Chicago
Summary
The primary goal of this study is to investigate if curcumin is beneficial for kidney transplant recipients, a population with extensive baseline vascular dysfunction and cognitive impairment who have few treatment options. The possible mechanisms by which curcumin improves vascular function will be evaluated as well as whether curcumin improves cognitive function in these patients.
Official title: A Pilot 12 Month, Randomized, Controlled Trial of Curcumin in Kidney Transplant Recipients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
14
Start Date
2019-11-01
Completion Date
2025-12
Last Updated
2025-09-05
Healthy Volunteers
No
Interventions
Curcumin
Patients will receive curcumin 2000 mg a day, for 12 months
Placebo
Patients will receive placebo capsule identical in appearance and taste to the supplement, for 12 months
Locations (1)
University of Illinois at Chicago
Chicago, Illinois, United States